$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000117891314000395 Filed on February 05, 2014

Income Statement

Concept	2014 Q1	2013 Q4	2012 Q4
Revenue	$95.00K	$95.00K	$195.0K
YoY Change	-51.03%	-51.28%	84315.58%
Cost Of Revenue	$3.000K	$3.000K	$6.000K
YoY Change	-50.0%	-50.0%	85614.29%
Gross Profit	$92.00K	$92.00K	$189.0K
YoY Change	-51.06%	-51.32%	84275.0%
Gross Profit Margin	96.84%	96.84%	96.92%
Selling, General & Admin	$2.530M	$1.980M	$1.420M
YoY Change	118.1%	39.44%	10.94%
% of Gross Profit	2750.0%	2152.17%	751.32%
Research & Development	$6.885M	$6.107M	$4.146M
YoY Change	38.67%	47.3%	139542.98%
% of Gross Profit	7483.7%	6638.04%	2193.65%
Depreciation & Amortization	$480.0K	$480.0K	$150.0K
YoY Change	54.84%	220.0%	50.0%
% of Gross Profit	521.74%	521.74%	79.37%
Operating Expenses	$6.885M	$6.107M	$4.146M
YoY Change	38.67%	47.3%	76.5%
Operating Profit	-$9.287M	-$6.990M	-$4.884M
YoY Change	56.53%	43.12%	230494.9%
Interest Expense	$10.00K	$290.0K	$390.0K
YoY Change	-96.0%	-25.64%	200.0%
% of Operating Profit
Other Income/Expense, Net	$11.00K	$285.0K	$394.0K
YoY Change	-95.65%	-27.66%
Pretax Income	-$9.280M	-$6.710M	-$4.490M
YoY Change	63.38%	49.44%	125.63%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$9.276M	-$6.705M	-$4.490M
YoY Change	63.31%	49.33%	225301.61%
Net Earnings / Revenue	-9764.21%	-7057.89%	-2302.56%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.41	-$1.09	-$0.78
COMMON SHARES
Basic Shares Outstanding	64.66M shares	59.88M shares	57.40M
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013 Q4	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$60.12M	$56.75M	$64.57M
YoY Change	0.48%	-12.11%	55.52%
Cash & Equivalents	$3.638M	$4.626M	$23.55M
Short-Term Investments	$56.48M	$52.12M	$41.03M
Other Short-Term Assets	$876.0K	$1.198M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$64.71M	$58.40M	$66.27K
YoY Change	5.89%	88023.19%	-99.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.13M	$11.45M	$10.03K
YoY Change	-3.27%	114093.1%	-99.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$320.0K	$320.0K	$760.0K
YoY Change	-59.49%	-57.89%	-36.13%
Other Assets	$18.00K	$26.00K	$1.305K
YoY Change	-84.07%	1892.34%	-99.9%
Total Long-Term Assets	$12.68M	$12.93M	$12.85K
YoY Change	-4.14%	100514.88%	-99.78%
TOTAL ASSETS
Total Short-Term Assets	$64.71M	$58.40M	$66.27K
Total Long-Term Assets	$12.68M	$12.93M	$12.85K
Total Assets	$77.39M	$71.33M	$79.12K
YoY Change	4.1%	90051.67%	-99.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.696M	$2.711M	$3.397K
YoY Change	4.62%	79705.71%	-99.71%
Accrued Expenses	$1.155M	$902.0K	$426.00
YoY Change	48.08%	211637.09%	-99.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.442M	$5.579M	$6.126K
YoY Change	11.74%	90970.85%	-99.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$611.0K	$633.0K	$3.950M
YoY Change	-13.82%	-83.97%	-8.35%
Total Long-Term Liabilities	$4.988M	$4.915M	$3.950K
YoY Change	9.55%	124330.38%	-99.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.442M	$5.579M	$6.126K
Total Long-Term Liabilities	$4.988M	$4.915M	$3.950K
Total Liabilities	$11.43M	$10.49M	$10.08K
YoY Change	10.78%	104048.47%	-99.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$107.6M	-$98.36M	-$74.23K
YoY Change	34.7%	132406.2%	-99.87%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$65.96M	$60.83M	$69.04M
YoY Change
Total Liabilities & Shareholders Equity	$77.39M	$71.33M	$79.12K
YoY Change	4.1%	90051.67%	-99.84%

Cashflow Statement

Concept	2014 Q1	2013 Q4	2012 Q4
OPERATING ACTIVITIES
Net Income	-$9.276M	-$6.705M	-$4.490M
YoY Change	63.31%	49.33%	225301.61%
Depreciation, Depletion And Amortization	$480.0K	$480.0K	$150.0K
YoY Change	54.84%	220.0%	50.0%
Cash From Operating Activities	-$5.660M	-$3.010M	-$3.370M
YoY Change	13.65%	-10.68%	2.43%
INVESTING ACTIVITIES
Capital Expenditures	$270.0K	$710.0K	$1.360M
YoY Change	-400.0%	-47.79%	65.85%
Acquisitions
YoY Change
Other Investing Activities	-$5.910M	-$920.0K	-$10.93M
YoY Change	-164.59%	-91.58%	271.77%
Cash From Investing Activities	-$6.170M	-$1.630M	-$12.29M
YoY Change	-166.77%	-86.74%	227.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.84M	670.0K	450.0K
YoY Change	36033.33%	48.89%	462.5%
NET CHANGE
Cash From Operating Activities	-5.660M	-3.010M	-3.370M
Cash From Investing Activities	-6.170M	-1.630M	-12.29M
Cash From Financing Activities	10.84M	670.0K	450.0K
Net Change In Cash	-990.0K	-3.970M	-15.21M
YoY Change	-123.08%	-73.9%	118.53%
FREE CASH FLOW
Cash From Operating Activities	-$5.660M	-$3.010M	-$3.370M
Capital Expenditures	$270.0K	$710.0K	$1.360M
Free Cash Flow	-$5.930M	-$3.720M	-$4.730M
YoY Change	21.27%	-21.35%	15.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64658887	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
	psti	Advance Payment For Development Costs AdvancePaymentForDevelopmentCosts	2000000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	465000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	53000	USD
CY2013Q4	psti	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInAOCI	7000	USD
CY2013Q2	psti	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInAOCI	9000	USD
CY2013Q4	psti	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInAOCI	108000	USD
CY2013Q2	psti	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInAOCI	302000	USD
CY2013Q4	psti	Available For Sale Securities Gross Unrealized Gain Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInAoci	1237000	USD
CY2013Q2	psti	Available For Sale Securities Gross Unrealized Gain Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInAoci	570000	USD
CY2013Q4	psti	Available For Sale Securities Gross Unrealized Loss Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInAoci	-115000	USD
CY2013Q2	psti	Available For Sale Securities Gross Unrealized Loss Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInAoci	-311000	USD
	psti	Business Combination Contingent Consideration Receivable Upon Certain Regulatory Milestones BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones	37500000	USD
	psti	Exercise Of Warrants By Investors And Finders ExerciseOfWarrantsByInvestorsAndFinders	1179000	USD
	psti	Exercise Of Warrants By Investors And Finders ExerciseOfWarrantsByInvestorsAndFinders	1679000	USD
CY2013Q4	psti	Forward Contracts Notional Amount ForwardContractsNotionalAmount	2000000	USD
	psti	Issuance Of Common Stock And Warrants Related To September2012 Public Offering IssuanceOfCommonStockAndWarrantsRelatedToSeptember2012PublicOffering	34106000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	1000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-102000	USD
	psti	Mutual Investment In Cha Agreement Amount MutualInvestmentInChaAgreementAmount	10414000	USD
	psti	Nonrefundable Payment For Development Costs NonrefundablePaymentForDevelopmentCosts	5000000	USD
	psti	Participation By Office Of Chief Scientist And Other Parties ParticipationByOfficeOfChiefScientistAndOtherParties	3374000	USD
	psti	Participation By Office Of Chief Scientist And Other Parties ParticipationByOfficeOfChiefScientistAndOtherParties	1543000	USD
CY2013Q4	psti	Participation By Office Of Chief Scientist And Other Parties ParticipationByOfficeOfChiefScientistAndOtherParties	1000000	USD
CY2012Q4	psti	Participation By Office Of Chief Scientist And Other Parties ParticipationByOfficeOfChiefScientistAndOtherParties	493000	USD
	psti	Purchase Of Property And Equipment In Credit PurchaseOfPropertyAndEquipmentInCredit	258000	USD
	psti	Purchase Of Property And Equipment In Credit PurchaseOfPropertyAndEquipmentInCredit	588000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	8230000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	6351000	USD
CY2013Q4	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	5107000	USD
CY2012Q4	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	3653000	USD
CY2013Q4	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	47000	USD
	psti	Shares To Be Issued In Exchange Of Shares Of Another Company Number Of Shares SharesToBeIssuedInExchangeOfSharesOfAnotherCompanyNumberOfShares	2500000	shares
	psti	Shares To Be Received In Stock Exchange Consideration SharesToBeReceivedInStockExchangeConsideration	1011504	shares
	psti	Stock Based Compensation To Contractor StockBasedCompensationToContractor		USD
	psti	Stock Based Compensation To Contractor StockBasedCompensationToContractor	1400000	USD
	psti	Stock Issued During Period Value Issued Under Cha Agreement StockIssuedDuringPeriodValueIssuedUnderChaAgreement	10414000	USD
	psti	Stock Issued During Period Value Share Based Compensation For Employees Directors And Certain Nonemployee Consultants StockIssuedDuringPeriodValueShareBasedCompensationForEmployeesDirectorsAndCertainNonemployeeConsultants	-2336000	USD
	psti	Stock Issued During Period Value Share Based Compensation For Employees Directors And Certain Nonemployee Consultants StockIssuedDuringPeriodValueShareBasedCompensationForEmployeesDirectorsAndCertainNonemployeeConsultants	-1684000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2711000	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2837000	USD
CY2013Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1290000	USD
CY2013Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1272000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	902000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1040000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1158000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	259000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158038000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	144109000	USD
CY2013Q4	us-gaap	Assets Assets	71328000	USD
CY2013Q2	us-gaap	Assets Assets	68316000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	58401000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	55085000	USD
CY2013Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12927000	USD
CY2013Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	13231000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	28776000	USD
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	13441000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27654000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	13182000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	3450000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	5122000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	34000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	32000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4626000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9007000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9389000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23548000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4381000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14159000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64392523	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59196617	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64392523	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59196617	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue		USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue		USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10561000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7991000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6201000	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4225000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12000	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	3000	USD
CY2012Q4	us-gaap	Cost Of Revenue CostOfRevenue	6000	USD
	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	7000000	USD
CY2013Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	297000	USD
CY2013Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	393000	USD
CY2013Q4	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500	shares
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3036000	USD
CY2013Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000	USD
CY2013Q4	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	1135000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	905000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	317000	USD
CY2013Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	421000	USD
	us-gaap	Depreciation Depreciation	937000	USD
	us-gaap	Depreciation Depreciation	276000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-57000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	342000	USD
CY2013Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-50000	USD
CY2012Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	189000	USD
	us-gaap	Description Of Location Of Foreign Currency Cash Flow Hedge Derivatives On Balance Sheet DescriptionOfLocationOfForeignCurrencyCashFlowHedgeDerivativesOnBalanceSheet	Other current assets
CY2013	us-gaap	Description Of Location Of Foreign Currency Cash Flow Hedge Derivatives On Balance Sheet DescriptionOfLocationOfForeignCurrencyCashFlowHedgeDerivativesOnBalanceSheet	-
	us-gaap	Description Of Location Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments On Balance Sheet DescriptionOfLocationOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsOnBalanceSheet	Other current assets
CY2013	us-gaap	Description Of Location Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments On Balance Sheet DescriptionOfLocationOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsOnBalanceSheet	Other current assets
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2013Q4	us-gaap	Foreign Currency Cash Flow Hedge Asset At Fair Value ForeignCurrencyCashFlowHedgeAssetAtFairValue	40000	USD
CY2013Q2	us-gaap	Foreign Currency Cash Flow Hedge Asset At Fair Value ForeignCurrencyCashFlowHedgeAssetAtFairValue		USD
CY2013Q4	us-gaap	Foreign Currency Derivative Assets At Fair Value ForeignCurrencyDerivativeAssetsAtFairValue	76000	USD
CY2013Q2	us-gaap	Foreign Currency Derivative Assets At Fair Value ForeignCurrencyDerivativeAssetsAtFairValue	93000	USD
CY2013Q4	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	36000	USD
CY2013Q2	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	93000	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-4000	USD
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties		USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-31000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3804000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3101000	USD
CY2013Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1975000	USD
CY2012Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1420000	USD
CY2013Q4	us-gaap	Grants Receivable GrantsReceivable	13891000	USD
	us-gaap	Gross Profit GrossProfit	184000	USD
	us-gaap	Gross Profit GrossProfit	378000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	92000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	189000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	35000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	488000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2179000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-167000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-48000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-96000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-977000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-190000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-389000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	401000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	808000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-7000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	3000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-116000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	577000	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	33000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71328000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68316000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5579000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5921000	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4915000	USD
CY2013Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4929000	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	28776000	USD
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	13441000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	164000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-23000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1179000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	35944000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	2547000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-14895000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8107000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6890000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11460000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8485000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-6705000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-4490000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	10414000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	390000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	589000	USD
CY2013Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	285000	USD
CY2012Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	394000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11850000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9074000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6990000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4884000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1198000	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	872000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1838000	USD
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-3000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	899000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	494000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	504000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	265000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	165000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	23000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	36000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
CY2013Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	36000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1028000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	494000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	491000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	265000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	633000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	680000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2694000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	7904000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	2204000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1169000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3338000	USD
CY2013Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1246000	USD
CY2013Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1023000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34106000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1179000	USD
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	521000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	7961000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-10646000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	583000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	304000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2963000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	459000	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	116000	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	9000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11449000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11866000	USD
	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	10000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11604000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7894000	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6107000	USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4146000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	456000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	316000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98362000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86902000	USD
	us-gaap	Revenues Revenues	190000	USD
	us-gaap	Revenues Revenues	390000	USD
CY2013Q4	us-gaap	Revenues Revenues	95000	USD
CY2012Q4	us-gaap	Revenues Revenues	195000	USD
CY2013Q4	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	13844000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1500	shares
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	23345000	USD
CY2013Q2	us-gaap	Short Term Investments ShortTermInvestments	31449000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	60834000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	57466000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	37742000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	69044000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	-278000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2336000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1962000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	146000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 16.9pt"> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; text-align: left"> Use of estimates</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt">  </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt">  </div> <!--EndFragment--></div> </div>
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60379352	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52659430	shares
CY2013Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	61510550	shares
CY2012Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57512930	shares

Files In Submission

Name	View Source	Status
0001178913-14-000395-index-headers.html	Edgar Link	pending
0001178913-14-000395-index.html	Edgar Link	pending
0001178913-14-000395.txt	Edgar Link	pending
0001178913-14-000395-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
psti-20131231.xml	Edgar Link	completed
psti-20131231.xsd	Edgar Link	pending
psti-20131231_cal.xml	Edgar Link	unprocessable
psti-20131231_def.xml	Edgar Link	unprocessable
psti-20131231_lab.xml	Edgar Link	unprocessable
psti-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1414310.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2014 Q1 Form 10-Q Financial Statement

#000117891314000395 Filed on February 05, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2014 Q1 Form 10-Q Financial Statement

#000117891314000395 Filed on February 05, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur